The findings indicated that patients on GLP-1RAs and/or DPP-4 inhibitors experienced better disease outcomes compared to those on different treatments, accompanied by an incidence rate ratio (IRR) of 0.52 (95% confidence interval: 0.420.65) [227]
Ozempic and other GLP-1 medications may contribute to bad breath indirectly
Medical supervision allows for proper side effect assessment and dosing adjustments
Mild nausea after eating, some burping or bloating , or occasional constipation
These treatments are now available in Wichita, KS, offering residents new hope in their health and confidence journeys
In Honesdale, Pennsylvania, Klinic offers comprehensive care through both injectable and oral forms, including the new Wegovy pill and Foundayo, for personalized treatment solutions